Trials / Completed
CompletedNCT04195932
Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- East Tennessee State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC).
Detailed description
A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise training |
Timeline
- Start date
- 1996-12-01
- Primary completion
- 1998-05-01
- Completion
- 1998-05-01
- First posted
- 2019-12-12
- Last updated
- 2019-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04195932. Inclusion in this directory is not an endorsement.